Comparison of Supine to Prone Position During Major Spinal Surgery
MRA-RACHIS
Alveolar Recruitment Maneuvers: Comparison of Supine to Prone Position During Major Spinal Surgery
1 other identifier
observational
30
1 country
1
Brief Summary
During mechanical ventilation, the alveolar recruitment maneuver (ARM) is to apply a positive end-expiratory pressure (PEEP) (generally 30 cm H2O) for a period of at least 30 seconds. The realization of MRA is one of three main elements of mechanical ventilation called "protective". This ventilatory strategy, originally described for the ventilation of acute respiratory distress syndrome (ARDS), and pulmonary and during abdominal surgery is based on a decrease tidal volumes, optimization of PEEP and the realization of MRA. Protective ventilation limit the occurrence of atelectasis, the surdistentions and, ultimately, significantly decreases postoperative complications. The MRA is currently recommended in the "major" surgery. Most spine surgery (eg transpedicular fixation) used in this definition, the MRA are indicated and now commonly used. This type of surgery requires further positioning the patient in the prone position (DV). The DV modifies the compliance of the chest respiratory characteristics and changes (increase in insufflation pressure) and hemodynamic (decreased venous return) of the patient. Respiratory and haemodynamic effects of MRA made VIS at major spine surgery are not known. The aim of this observational study, non-interventional, is to compare the hemodynamic and respiratory effects of MRA performed in DV to those of MRA performed in the prone position (DD). The investigators hypothesis is that the respiratory and hemodynamic consequences of MRA performed in DV is different from those conducted in DD. A better understanding of hemodynamic and respiratory characteristics of MRA performed in DV would provide a more tailored to this type of surgery respiratory optimization strategy and reduce respiratory complications of this surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedFirst Posted
Study publicly available on registry
November 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedSeptember 5, 2025
September 1, 2025
2.8 years
October 2, 2014
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The hemodynamic and respiratory data are collected before, during and after the completion of 3 ARM (alveolar recruitment maneuver):
T1: ARM (in a supine position) (before setting prone position); T2: ARM (prone position) ; T3: ARM at acute respiratory distress syndrome [ARDS] (end of intervention, after supine position); (* At the end of ARM, only hemodynamic data are collected)
Interventions
Eligibility Criteria
Patient operated major spine surgery, including: * The transpedicular osteotomies * Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic * Degenerative spinal surgery on multiple vertebral levels and degraded land * Surgery of scoliosis * Recovery of spinal surgery on several levels * Sepsis spinal presumed origin
You may qualify if:
- Adult patient
- Patient operated major spine surgery, including:
- The transpedicular osteotomies
- Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic
- Degenerative spinal surgery on multiple vertebral levels and degraded land
- Surgery of scoliosis
You may not qualify if:
- Inability to give informed patient information (eg difficulty of understanding)
- Patient under guardianship - Patient pregnant or during lactation - Detainees or under judicial protection.
- contraindications to MRA: emphysema, pneumothorax, major hypovolemia, hemodynamic instability defined as systolic blood pressure below 90 mmHg or tachycardia greater than 110 bpm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service D'Anesthesiologie - Nhc
Strasbourg, 67091, France
Study Officials
- PRINCIPAL INVESTIGATOR
COLLANGE Olivier, MD
Strasbourg University Hospital, France
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2014
First Posted
November 7, 2014
Study Start
November 1, 2014
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
September 5, 2025
Record last verified: 2025-09